There was a trend toward increased CD4+ T cell frequency in CLL patients compared to HCs (Figure 3A), and the absolute numbers were significantly elevated in the CLL group (Figure 3B). This evidence concerns the gene CD4 and B-cell chronic lymphocytic leukemia.